@article{article, title = {{Improved tumor response and survival outcomes with post-transplant bortezomib (Btz) consolidation versus observation (Obs) alone in patients with newly diagnosed multiple myeloma (MM): Results from a randomized, open-label, multicenter, parallel-group phase 2 study}}, publisher = {{Elsevier BV}}, url = {{}}, year = {{2015}}, month = {{9}}, author = {{Sezer O and Terpos E and Hajek R and Sucak G and Cagirgan S and Linkesch W and Akay OM and Armbrecht G and Plesner T and Snowden JA and Nahi H et al}}, doi = {{10.1016/j.clml.2015.07.323}}, volume = {{15}}, journal = {{Clinical Lymphoma Myeloma and Leukemia}}, pages = {{e129-e130}}, note = {{Accessed on 2024/12/28}}}